Merck Drops ITC Probe Into Patented Folate Supplements

Law360, New York (June 11, 2013, 7:25 PM EDT) -- A subsidiary of Swiss Merck KgaA and others have asked the U.S. International Trade Commission to drop its probe into allegations that smaller rivals were importing generic folate supplements that contained patent-protected ingredients, according to papers filed Monday.

Merck & Cie, Pamlab LLC — now a Nestle S.A. subsidiary — and South Alabama Medical Science Foundation asked the trade body to halt its investigation into Gnosis SpA, Macoven Pharmaceuticals Inc. and Viva Pharmaceutical Inc. while the agency considers joint motions to terminate the probe.

Merck and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.